$2.455
-0.115[-4.47%]
At close: Apr 25
$2.455
0[0.00%]
After Hours: 4:00PM EDT
Vivos Therapeutics
(NASDAQ:VVOS)Vivos Therapeutics Stock (NASDAQ:VVOS), Analyst Ratings, Price Targets, Predictions
Vivos Therapeutics Inc has a consensus price target of $6.25, established from looking at the 3 latest analyst ratings. The last 3 analyst ratings were released from Ascendiant Capital, Roth Capital, and Roth Capital on January 17, 2023, August 13, 2021, and May 18, 2021. With an average price target of $7.83 between Ascendiant Capital, Roth Capital, and Roth Capital, there's an implied 219.08% upside for Vivos Therapeutics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Ascendiant Capital
Roth Capital
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Vivos Therapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/17/2023 | VVOS | Buy Now | Vivos Therapeutics | $2.46 | 1.83% | Ascendiant Capital | Edward Woo | → $62.5 | Initiates | → Buy | Get Alert |
| 08/13/2021 | VVOS | Buy Now | Vivos Therapeutics | $2.46 | 307.33% | Roth Capital | Scott Henry | $275 → $250 | Maintains | Buy | Get Alert |
| 05/18/2021 | VVOS | Buy Now | Vivos Therapeutics | $2.46 | 348.07% | Roth Capital | Scott Henry | $300 → $275 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Vivos Therapeutics (VVOS)?
The latest price target for Vivos Therapeutics (NASDAQ: VVOS) was reported by Ascendiant Capital on January 17, 2023. The analyst firm set a price target for $2.50 expecting VVOS to rise to within 12 months (a possible 1.83% upside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Vivos Therapeutics (VVOS)?
The latest analyst rating for Vivos Therapeutics (NASDAQ: VVOS) was provided by Ascendiant Capital, and Vivos Therapeutics initiated their buy rating.
When was the last upgrade for Vivos Therapeutics (VVOS)?
There is no last upgrade for Vivos Therapeutics.
When was the last downgrade for Vivos Therapeutics (VVOS)?
There is no last downgrade for Vivos Therapeutics.
When is the next analyst rating going to be posted or updated for Vivos Therapeutics (VVOS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vivos Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vivos Therapeutics was filed on January 17, 2023 so you should expect the next rating to be made available sometime around January 17, 2024.
Is the Analyst Rating Vivos Therapeutics (VVOS) correct?
While ratings are subjective and will change, the latest Vivos Therapeutics (VVOS) rating was a initiated with a price target of $0.00 to $2.50. The current price Vivos Therapeutics (VVOS) is trading at is $2.46, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.